12:00 AM
 | 
May 03, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Onconase: Completed Phase III trial

Alfacell Corp. (ACEL), Bloomfield, N.J.
Product: Onconase
Business: Cancer
Therapeutic category: Cytotoxic...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >